Cary Street Partners Investment Advisory’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215K | Sell |
2,003
-182
| -8% | -$19.5K | 0.1% | 225 |
|
|
2025
Q1 | $220K | Buy |
2,185
+147
| +7% | +$14.8K | 0.13% | 197 |
|
|
2024
Q4 | $182K | Sell |
2,038
-17,299
| -89% | -$1.55M | 0.12% | 194 |
|
|
2024
Q3 | $1.62M | Sell |
19,337
-681
| -3% | -$57.1K | 0.06% | 294 |
|
|
2024
Q2 | $1.54M | Buy |
20,018
+188
| +0.9% | +$14.5K | 0.06% | 292 |
|
|
2024
Q1 | $1.36M | Buy |
19,830
+260
| +1% | +$17.8K | 0.06% | 300 |
|
|
2023
Q4 | $1.13M | Buy |
19,570
+347
| +2% | +$20.1K | 0.05% | 296 |
|
|
2023
Q3 | $1.01M | Buy |
19,223
+1,079
| +6% | +$57K | 0.05% | 303 |
|
|
2023
Q2 | $981K | Sell |
18,144
-720
| -4% | -$38.9K | 0.06% | 259 |
|
|
2023
Q1 | $944K | Sell |
18,864
-53
| -0.3% | -$2.65K | 0.07% | 245 |
|
|
2022
Q4 | $875K | Buy |
18,917
+18
| +0.1% | +$833 | 0.06% | 253 |
|
|
2022
Q3 | $732K | Buy |
18,899
+538
| +3% | +$20.8K | 0.06% | 266 |
|
|
2022
Q2 | $684K | Buy |
+18,361
| New | +$684K | 0.06% | 260 |
|
|
2020
Q4 | – | Sell |
-58
| Closed | -$2K | – | 420 |
|
|
2020
Q3 | $2K | Buy |
+58
| New | +$2K | ﹤0.01% | 905 |
|